3/4
03:32 pm
roiv
A Look At Roivant Sciences (ROIV) Valuation After Recent Share Price Strength [Yahoo! Finance]
Low
Report
A Look At Roivant Sciences (ROIV) Valuation After Recent Share Price Strength [Yahoo! Finance]
3/4
09:03 am
roiv
Roivant Sciences (ROIV) had its "buy" rating reaffirmed by TD Cowen.
Low
Report
Roivant Sciences (ROIV) had its "buy" rating reaffirmed by TD Cowen.
3/4
08:39 am
roiv
Moderna rises as up to $2.25 billion settlement for COVID vaccine patent dispute to remove overhang [Yahoo! Finance]
Low
Report
Moderna rises as up to $2.25 billion settlement for COVID vaccine patent dispute to remove overhang [Yahoo! Finance]
3/4
08:38 am
roiv
Moderna rises as up to $2.25 billion settlement for COVID vaccine patent dispute to remove overhang [Yahoo! Finance Canada]
Low
Report
Moderna rises as up to $2.25 billion settlement for COVID vaccine patent dispute to remove overhang [Yahoo! Finance Canada]
3/4
08:00 am
roiv
Roivant Sciences (ROIV) had its price target raised by HC Wainwright from $33.00 to $34.00. They now have a "buy" rating on the stock.
Medium
Report
Roivant Sciences (ROIV) had its price target raised by HC Wainwright from $33.00 to $34.00. They now have a "buy" rating on the stock.
3/4
05:34 am
roiv
What Roivant Sciences (ROIV)'s Priority FDA Review for Brepocitinib in Dermatomyositis Means For Shareholders [Yahoo! Finance]
Medium
Report
What Roivant Sciences (ROIV)'s Priority FDA Review for Brepocitinib in Dermatomyositis Means For Shareholders [Yahoo! Finance]
3/3
04:36 pm
roiv
Moderna agrees to pay up to $2.25 billion to settle COVID vaccine patent dispute [Yahoo! Finance]
Medium
Report
Moderna agrees to pay up to $2.25 billion to settle COVID vaccine patent dispute [Yahoo! Finance]
3/3
04:34 pm
roiv
Roivant Announces Genevant Sciences' and Arbutus Biopharma's $2.25 Billion Global Settlement With Moderna [Yahoo! Finance]
Medium
Report
Roivant Announces Genevant Sciences' and Arbutus Biopharma's $2.25 Billion Global Settlement With Moderna [Yahoo! Finance]
3/3
04:15 pm
roiv
Roivant Announces Genevant Sciences’ and Arbutus Biopharma’s $2.25 Billion Global Settlement With Moderna
Medium
Report
Roivant Announces Genevant Sciences’ and Arbutus Biopharma’s $2.25 Billion Global Settlement With Moderna
3/3
02:12 pm
roiv
Roivant Sciences (ROIV) had its "buy" rating reaffirmed by Jefferies Financial Group Inc..
Low
Report
Roivant Sciences (ROIV) had its "buy" rating reaffirmed by Jefferies Financial Group Inc..
3/3
07:00 am
roiv
Priovant Announces FDA Acceptance and Priority Review of New Drug Application for Brepocitinib in Dermatomyositis
Low
Report
Priovant Announces FDA Acceptance and Priority Review of New Drug Application for Brepocitinib in Dermatomyositis
2/10
06:52 pm
roiv
Roivant Sciences (NASDAQ:ROIV) was downgraded by analysts at
Weiss Ratings from a "hold (c-)" rating to a "sell (d)" rating.
Low
Report
Roivant Sciences (NASDAQ:ROIV) was downgraded by analysts at
Weiss Ratings from a "hold (c-)" rating to a "sell (d)" rating.
2/10
07:14 am
roiv
Roivant Sciences (NASDAQ:ROIV) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Low
Report
Roivant Sciences (NASDAQ:ROIV) had its "buy" rating reaffirmed by analysts at HC Wainwright.
2/10
07:13 am
roiv
Roivant Sciences (NASDAQ:ROIV) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
Low
Report
Roivant Sciences (NASDAQ:ROIV) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
2/9
09:04 am
roiv
Roivant Sciences (NASDAQ:ROIV) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Medium
Report
Roivant Sciences (NASDAQ:ROIV) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
2/9
07:20 am
roiv
Roivant Sciences (NASDAQ:ROIV) had its "buy" rating reaffirmed by analysts at Guggenheim.
Medium
Report
Roivant Sciences (NASDAQ:ROIV) had its "buy" rating reaffirmed by analysts at Guggenheim.
2/8
08:56 pm
roiv
Roivant Sciences (ROIV) Valuation Check After Strong Share Price Momentum [Yahoo! Finance]
Medium
Report
Roivant Sciences (ROIV) Valuation Check After Strong Share Price Momentum [Yahoo! Finance]
2/7
06:48 am
roiv
Roivant Sciences (ROIV) Soars 19.4% as Pipeline Drugs Progress [Yahoo! Finance]
Medium
Report
Roivant Sciences (ROIV) Soars 19.4% as Pipeline Drugs Progress [Yahoo! Finance]
2/6
10:01 pm
roiv
Roivant Sciences (NASDAQ:ROIV) had its "buy" rating reaffirmed by analysts at TD Cowen.
Medium
Report
Roivant Sciences (NASDAQ:ROIV) had its "buy" rating reaffirmed by analysts at TD Cowen.
2/6
07:12 pm
roiv
Roivant Sciences Ltd. (ROIV) Reports Q3 Loss, Misses Revenue Estimates [Yahoo! Finance]
Medium
Report
Roivant Sciences Ltd. (ROIV) Reports Q3 Loss, Misses Revenue Estimates [Yahoo! Finance]
2/6
02:13 pm
roiv
Roivant Sciences Ltd (ROIV) Q3 2025 Earnings Call Highlights: Strategic Advances and Financial ... [Yahoo! Finance]
Low
Report
Roivant Sciences Ltd (ROIV) Q3 2025 Earnings Call Highlights: Strategic Advances and Financial ... [Yahoo! Finance]
2/6
01:26 pm
roiv
Immunovant, Inc. (IMVT) Q3 2026 Earnings Call Transcript [Seeking Alpha]
Medium
Report
Immunovant, Inc. (IMVT) Q3 2026 Earnings Call Transcript [Seeking Alpha]
2/6
10:36 am
roiv
Roivant Sciences Q3 Earnings Call Highlights [Yahoo! Finance]
Medium
Report
Roivant Sciences Q3 Earnings Call Highlights [Yahoo! Finance]
2/6
09:07 am
roiv
Pfizer – Roivant tie-up generates positive mid-stage data for lead asset [Seeking Alpha]
Medium
Report
Pfizer – Roivant tie-up generates positive mid-stage data for lead asset [Seeking Alpha]
2/6
08:11 am
roiv
Priovant's Brepocitinib Shows Skin Disease Improvement in Phase 2 Study; Pulmovant Completes Lung Disease Trial Enrollment [Yahoo! Finance]
Low
Report
Priovant's Brepocitinib Shows Skin Disease Improvement in Phase 2 Study; Pulmovant Completes Lung Disease Trial Enrollment [Yahoo! Finance]